How Is Oscar Health (OSCR) Moving After Today's Reports?

Oscar Health rose 65.73% during the aftermarket session to $5.95 per share. As reported by Barrons: "A leadership announcement sent shares of health insurance company Oscar Health flying on Tuesday. Oscar ( ticker: OSCR ) said that Mark Bertolini, the former chairman and chief executive officer of Aetna, would assume the role of CEO effective April 3." You can read more about it here. For those of you thinking about investing in the stock, here is a brief look at the company's fundamentals.

Oscar Health, Inc. offers health insurance products and services to individuals, families, and businesses in the United States. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 14.34 and an average price to book (P/B) ratio of 1.57. In contrast, Oscar Health has a trailing 12 month P/E ratio of -2.1 and a P/B ratio of 0.532.

Oscar Health has moved -64.67% over the last year compared to -14.12% for the S&P 500 -- a difference of -50.55%. Oscar Health has a 52 week high of $10.53 and a 52 week low of $2.05. At today's price of $5.95 per share, Oscar Health is 12.47% away from its target price of $5.29, and on average, analysts give the stock a rating of hold. 7.08% of the company's shares are linked to short positions, and 85.07% of the shares are owned by institutional investors.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.